[
  {
    "ts": null,
    "headline": "Should Abbott’s AI-Powered Libre Assist Shift Its Diabetes Platform Strategy Narrative for ABT Investors?",
    "summary": "In early January 2026, Abbott Laboratories unveiled Libre Assist, an AI-powered feature within its Libre app that helps U.S. diabetes patients predict the glucose impact of meals in real time by analyzing food photos or descriptions and integrating data from its FreeStyle Libre continuous glucose monitoring sensors. By combining generative AI with continuous glucose data to give pre-meal guidance and post-meal feedback, Libre Assist highlights Abbott’s push to turn its Libre ecosystem into a...",
    "url": "https://finnhub.io/api/news?id=56bbab62a138852287c687a18ff5b7fc7f9658e412be2bc4e0c12199db122a52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767704820,
      "headline": "Should Abbott’s AI-Powered Libre Assist Shift Its Diabetes Platform Strategy Narrative for ABT Investors?",
      "id": 138000169,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "In early January 2026, Abbott Laboratories unveiled Libre Assist, an AI-powered feature within its Libre app that helps U.S. diabetes patients predict the glucose impact of meals in real time by analyzing food photos or descriptions and integrating data from its FreeStyle Libre continuous glucose monitoring sensors. By combining generative AI with continuous glucose data to give pre-meal guidance and post-meal feedback, Libre Assist highlights Abbott’s push to turn its Libre ecosystem into a...",
      "url": "https://finnhub.io/api/news?id=56bbab62a138852287c687a18ff5b7fc7f9658e412be2bc4e0c12199db122a52"
    }
  }
]